Vanda Pharmaceuticals Inc.

VNDA | NASDAQ

Price Alert Chart Builder DCF Calculator

$5.15

$0 (-0.10%)

Sep 22, 2026, 11:59 AM ET · Market open

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Income Statement Balance Sheet Cashflow Statement Ratios

Annual Quarterly TTM

Fiscal Year Period Ending	FY 2025 Dec 30, 2025	FY 2024 Dec 30, 2024	FY 2023 Dec 30, 2023	FY 2022 Dec 30, 2022	FY 2021 Dec 30, 2021	FY 2020 Dec 30, 2020
Revenue	216.11M	198.77M	192.64M	254.38M	268.68M	248.17M
Cost of Revenue	13.04M	11.31M	14.8M	24.28M	25.63M	23.36M
Gross Profit	203.06M	187.46M	177.84M	230.1M	243.05M	224.8M
Operating Income	-151.17M	-40.66M	-13.95M	6.33M	42.17M	27.24M
Interest Income	n/a	n/a	n/a	n/a	199K	4.42M
Pretax Income	-138.65M	-22.92M	6.34M	11.3M	42.36M	31.66M
Net Income	-220.47M	-18.9M	2.51M	6.28M	33.15M	23.34M
Selling & General & Admin	237.95M	146.41M	112.88M	136.49M	124.05M	140.51M
Research & Development	109.27M	74.43M	76.82M	85.77M	75.36M	55.58M
Other Expenses	7.01M	7.27M	2.09M	1.52M	1.48M	1.48M
Operating Expenses	354.23M	228.12M	191.8M	223.77M	200.89M	197.57M
Interest Expense	n/a	n/a	n/a	n/a	n/a	n/a
Selling & Marketing Expenses	n/a	1.9M	500K	2.6M	6.7M	12.6M
Cost & Expenses	367.27M	239.43M	206.59M	248.05M	226.52M	220.93M
Income Tax Expense	81.83M	-4.02M	3.83M	5.03M	9.21M	8.32M
Shares Outstanding (Basic)	58.93M	58.15M	57.38M	56.46M	55.55M	54.43M
Shares Outstanding (Diluted)	58.93M	58.15M	57.56M	56.98M	56.92M	55.19M
EPS (Basic)	-3.74	-0.32	0.04	0.11	0.60	0.43
EPS (Diluted)	-3.74	-0.32	0.04	0.11	0.58	0.42
EBITDA	-126.73M	-14.79M	9.35M	14.03M	45.21M	34.52M
EBIT	-138.65M	-22.92M	6.34M	11.3M	42.36M	31.66M
Depreciation & Amortization	11.92M	8.13M	3.01M	2.73M	2.84M	2.86M